CheckMyRecalls

Aurobindo Pharma USA Inc recalls Dicyclomine Hydrochloride Capsules

Published
12 Aug 2026
Units affected
6,408 bottles distributed to market
Agency
FDA
Country
United States

The hazard

Shortfill; reports of empty capsules.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99

Brand / company
Aurobindo Pharma USA Inc
Codes / lots
Batch # DMC125018A, Exp Date: 07/2027.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 12 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.